- $26.69bn
- $22.12bn
- $1.94bn
Brief: Sanofi's Nuvaxovid Covid-19 Vaccine Showed Better Tolerability Than Mnexspike In Head-To-Head Study
Brief: OpenAI launches AI model GPT-Rosalind for life sciences research
U.S. RESEARCH ROUNDUP-Autodesk, Citigroup, Wells Fargo
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
US CDC delays publishing report showing COVID vaccine benefits, WaPo reports
Rare disease advocacy group urges Trump administration to restore FDA clarity
Brief: Moderna Says CEO Stéphane Bancel's 2025 Total Compensation Was $19.9 Million - SEC Filing
US judge blocks efforts to reshape childhood vaccine policy (updated)
Factbox: US Health Secretary Kennedy's vaccine actions and policy positions
Moderna shares rise after US judge blocks attempts to reshape vaccine policy
US judge blocks efforts to reshape childhood vaccine policy
GSK gets US FDA approval for expanded use of RSV vaccine (updated)
GSK gets US FDA approval for expanded use of RSV vaccine
US vaccine advisers drop plan to question mRNA COVID shots, WaPo reports (updated)
US vaccine advisers drop plan to question mRNA COVID shots, WaPo reports
Jefferies cuts Rovi to 'hold' as visibility fades, risks mount
U.S. RESEARCH ROUNDUP-Broadcom, CNX Resources, Veeva Systems
U.S. STOCKS ON THE MOVE-AnaptysBio, Tesla, Intel
U.S. STOCKS ON THE MOVE-Dycom Industries, Robinhood, Brown-Forman